Journals

The European Society for Medical Oncology (ESMO) Annual Congress was held in Berlin, Germany between October 17th–21st, 2025…

Regina Berkovich and Robert Shin share their insights for this article on the evolving role of a selective S1P receptor modulator in early relapsing MS…

Treatment of early breast cancer (eBC) is continuing to advance, and pivotal PhaseIII trial data released at the San Antonio Breast Cancer…

Invasive fungal infections remain a serious concern in patients with hematologic malignancies. In this expert interview, Hana F. Safah…

JAK inhibitors have expanded options for managing alopecia areata, but questions remain around patient selection, monitoring, and…

Treatment for advanced non-small cell lung cancer (NSCLC) with activating mutations in HER2 relies on chemo-immunotherapy in the…

Data presented at the European Society for Medical Oncology (ESMO) Congress 2025 signal a potential shift in the management of early-stage…

Explore the latest AMJ Rheumatology issue with American College of Rheumatology (ACR) Convergence 2025 highlights including the use of…

This special issue brings you IDWeek 2025 highlights on HIV prevention, infectious disease challenges in correctional settings, and…

Patients with skin of color are under-represented in atopic dermatitis (AD) clinical trials, despite higher incidence and persistence…

The FDA has now approved zongertinib, a tyrosine kinase inhibitor, for the treatment of adult patients with unresectable or metastatic…

BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate exacerbation…

Explore the latest issue of AMJ Oncology, featuring expert insights from American Society of Clinical Oncology (ASCO) 2025, new research…

New findings explore the efficacy and safety of deucravacitinib in moderate-to-severe plaque psoriasis, including scalp outcomes and…

The latest issue of AMJ Respiratory centers on evidence-based approaches that directly impact patient outcomes. From lung transplant…

New findings from an extended analysis of the CheckMate 274 trial offer fresh insight into post-surgical treatment for high-risk…

This issue features expert commentary from the 2025 American Academy of Neurology (AAN) Annual Meeting, high-impact original articles…

Prostate cancer progression remains a major challenge in metastatic hormone-sensitive prostate cancer, despite therapeutic advances, and…

In this new article, discover recent clinical insights on clascoterone cream 1% and its potential role in addressing excess sebum…

In this issue of AMJ Dermatology, dive into expert-led coverage of AAD 2025, including highlights on environmental dermatology, JAK…

A new study shows how gene expression profiling improves risk prediction for high-risk cutaneous squamous cell carcinoma, helping…

This poster was presented at the Conference on Retroviruses and Opportunistic Infections (CROI), held in San Francisco, California, USA…

Notable recent additions to dermatologists’ acne toolkit include newer dual and triple combination therapies, as well as agents with…

Read our latest publication to learn about the epithelial cytokines thymic stromal lymphopoietin (TSLP), IL-25, and IL-33, which can be…